Employer Ledger
Records as ofOFLC30 Jun 2026OSHA23 Sep 2026300A2023 to 2025WHD15 Jun 2026USAspendingread 2 Oct 2026NLRBno data

Regeneron Pharmaceuticals, Inc.: H-1B filings and workplace records, Tarrytown, New York

Industry Professional, Scientific, and Technical Services (NAICS 54171)5,100 employees reported469 federal recordsNewest record

Regeneron Pharmaceuticals, Inc. filed 292 labor condition applications (LCA) in fiscal year 2026, to 30 June 2026. OFLC certified 291 of them. The median offered wage on its LCAs in fiscal years 2025 to 2026 is $152,375 a year. It filed 3 PERM applications in fiscal year 2026, to 30 June 2026. OFLC certified all of them. An LCA is a filing. It is not a visa and it is not a job.

Is this the same company?

The site joins the records of each agency by employer name and by state. It has no other key.

A record on this page can belong to a different firm that has the same name.

How the site matches records

Since the last update

No change. The site tracks the LCA filings, PERM applications, OSHA inspections and back wages of this employer record. Changes and data dates

H-1B and PERM: Office of Foreign Labor Certification

Decisions to Newest file fiscal year 2026, quarter 3Read from the committed copy

Employer-specific case information that appears on this website was provided to OFLC by employers who submitted prevailing wage, labor certification and labor attestation applications for processing. These are not employer responses to the Bureau of Labor Statistics' Occupational Employment Statistics (BLS-OES) survey.

Any typographical errors or other data anomalies (e.g., incomplete or blank data fields, etc.) may be due to internal data entry or other external customer errors in completing and submitting the applications for processing.

A small percentage of determinations may be subject to change in subsequent quarterly releases due to appeal or redetermination decisions on employer applications.

The words of the Office of Foreign Labor Certification. Source: Performance Data, read .

LCA filings, fiscal year 2026
29299.6% certified, year to date
Median offered wage
$152,375a year; prevailing $111,966
Worker positions
979fiscal years 2025 to 2026
PERM applications, fiscal year 2026
3100% certified
Regeneron Pharmaceuticals, Inc.: LCA filings by fiscal year fiscal year 2026 is to 30 Jun 2026
Fiscal yearFilingsCertifiedCertified shareDeniedWithdrawn
202515915799%02
202629229199.6%01
Regeneron Pharmaceuticals, Inc.: offered wages by job title fiscal years 2025 to 2026
Job titleMedian offered wageLCA filings
Principal Scientist$159,91934
Senior Scientist$143,35826
Associate Scientist$90,00019
Sr Scientist$144,50318
Scientist$115,70912
Principal Statistical Programmer$152,50011
Senior Associate Scientist$99,54810
Postdoctoral Fellow$99,48510
Staff Engineer$159,2748
Sr Assoc Scientist$99,3678
Principal Biostatistician$150,3838
Sr Associate Scientist$99,8918

A wage is a year: the rate on the form times its unit, so an hourly rate times 2,080. A median needs three or more applications that state a wage. The list holds the twelve most frequent job titles.

Prevailing wage levels on the filings

Regeneron Pharmaceuticals, Inc.: LCA filings by prevailing wage level
LevelFilingsShare
Level I82%
Level II25857%
Level III11024%
Level IV7116%
Not stated41%
Regeneron Pharmaceuticals, Inc.: LCA filings by occupation
Occupation (SOC)LCA filingsMedian offered wage, all employers
Biochemists and Biophysicists86$77,898
Bioinformatics Scientists63$82,100
Statisticians51$127,075
Data Scientists46$123,741
Natural Sciences Managers27$125,170
Chemists25$88,508
Computer and Information Systems Managers22$200,006
Medical Scientists, Except Epidemiologists21$75,000
Regeneron Pharmaceuticals, Inc.: LCA filings by worksite state
Worksite stateLCA filings
New York351
New Jersey77
Massachusetts15
North Carolina2
Pennsylvania2
Washington1
Florida1
Virginia1

OFLC files an LCA under the state of the employer address on the form (New York). The worksites can be in other states.

PERM applications (permanent labor certification)

Regeneron Pharmaceuticals, Inc.: PERM applications by fiscal year fiscal year 2026 is to 30 Jun 2026
Fiscal yearApplicationsCertifiedDeniedWithdrawn
20249900
20255500
20263300
Regeneron Pharmaceuticals, Inc.: PERM applications by job title
Job titleApplications
Associate Scientist3
Senior Statistical Programmer2
Manager, Clinical Data Science1
Manager Global Patient Safety1
Associate Manager, CMC Regulatory Affairs1
Senior Manager Statistical Programming1
Statistical Programmer1
R&D Specialist1
R&D Associate1
Senior Developer1
Regeneron Pharmaceuticals, Inc.: PERM applications by occupation
Occupation (SOC)Applications
Molecular and Cellular Biologists1
Software Developers1
Chemists1
Mechatronics Engineers1
Statisticians1
Computer and Information Systems Managers1
Data Scientists1
Computer Systems Analysts1

Fiscal year 2024 holds the applications on the new Form 9089 only. The median offered wage on the PERM applications is $110,926 a year.

Injury summaries: OSHA Injury Tracking Application, Form 300A

Calendar years 2023 to 2025Read from the committed copy

While OSHA takes multiple steps to ensure the data collected are accurate, problems and errors invariably exist for some establishments. Efforts are made during the collection cycle to correct submission errors; however, some remain unresolved. OSHA does not validate the employee or injury and illness counts reported by establishments.

Recording or reporting a work-related injury, illness, or fatality does not mean that the employer or employee was at fault, that an OSHA rule has been violated, or that the employee is eligible for workers' compensation or other benefits.

The words of the Occupational Safety and Health Administration. Source: Injury Tracking Application (ITA) Data, read .

Total recordable case rate, 2025
0.5cases for each 100 full-time workers
Days away, restricted or transferred (DART), 2025
0.3
Employees reported, 2025
5,1001 establishment
Recordable cases, 2025
250 deaths
Regeneron Pharmaceuticals, Inc.: case rate beside other establishments, 2025
GroupTotal recordable case rate
This record0.5
Median establishment, NAICS 5410.0
All establishments, NAICS 5411.2
All establishments, New York3.8
All establishments, United States3.5
Regeneron Pharmaceuticals, Inc.: Form 300A summaries by year
YearEstablishmentsEmployeesHours workedDeathsDays awayRestricted or transferredOther casesCase rateDART rate
202314,4509,706,0230111250.60.5
202414,91610,476,810013640.40.4
202515,10010,896,54909880.50.3

The figures add up every establishment that filed under this name in New York. A rate is blank when the establishments reported fewer than 2,000 hours. The median establishment has 20,000 hours or more.

Federal contracts: USAspending.gov

Period the latest 12 monthsRead from the agency

There are various reasons financial or award data is not reported by agencies or otherwise available to USAspending.gov at a given time. These include, but are not limited to, timing of data availability, or sensitive data that is not subject to submission. Where possible, USAspending.gov advises readers that other information exists that cannot be detailed.

The words of the USAspending.gov. Source: About the Data, glossary entry Unreported Data, read .

Contract obligations, latest 12 months
$279M
Recipient level
ChildUEI N3F9MH7E6HD6

USAspending lists Regeneron Pharmaceuticals Inc among the 3,903 largest federal contract recipients. The site matches the name across all states, so the total is for the whole company. USAspending credits Dun and Bradstreet (D&B) for some recipient data. Data sources

Regeneron Pharmaceuticals Inc: contract obligations by fiscal year
Fiscal yearObligations
2022$494K
2023$326M
2024$0
2025$-331,708,160
2026$279M
2027$0
Regeneron Pharmaceuticals Inc: obligations by awarding agency
AgencyObligations
Department of Health and Human Services$274M
Department of Veterans Affairs$494K

No record at these agencies

OSHA

OSHA inspections

The enforcement data since 2016 has no OSHA inspection of this employer in New York. OSHA records an inspection at the establishment, so sites in other states are under those states.

Records to . Inspections opened since 2016. Read from the agency.

WHD

Back wages

The data since fiscal year 2005 has no concluded Wage and Hour Division case of this employer in New York.

Concluded cases to . Cases since fiscal year 2005. Read from the agency.

NLRB

Union elections

The site holds no NLRB election results at this time. nlrb.gov did not accept the requests of the site, so the copy is empty.

Data none, the copy on this site is empty. Not read from the agency.

Other employers in New York

These links help you move through the records. The list is in name order. It is not a ranking.

Professional, Scientific, and Technical Services in New York

Questions about this record

What happened to the LCAs of Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. filed 451 LCAs in fiscal years 2025 to 2026. OFLC certified 448 of them. OFLC denied none. The employer withdrew 3.
Which job title is most frequent on the LCAs of Regeneron Pharmaceuticals, Inc.?
The job title Principal Scientist has 34 filings. Its median offered wage is $159,919 a year.
Which prevailing wage levels do the LCAs state?
The LCAs state Level I in 2%, Level II in 57%, Level III in 24% and Level IV in 16%, and no level in 1%. The employer states the level on the form.
Has OSHA inspected Regeneron Pharmaceuticals, Inc. in New York?
The enforcement data since 2016 has no OSHA inspection of this employer in New York. Sites in other states have their own records.

Official channels

Cite this page

Employer Ledger. "Regeneron Pharmaceuticals, Inc. (New York)." https://employerledger.com/employer/regeneron-pharmaceuticals-inc-ny/. Records of: Office of Foreign Labor Certification; OSHA Injury Tracking Application, Form 300A; USAspending.gov. Newest record .

The address of this page does not change. The figures change when an agency publishes new records.

Where the figures come from

  • OFLC Office of Foreign Labor Certification. Decisions to . Newest file fiscal year 2026, quarter 3. Read , from the committed copy.
  • OSHA Occupational Safety and Health Administration. Records to . Inspections opened since 2016. Read , from the agency.
  • 300A OSHA Injury Tracking Application, Form 300A. Calendar years 2023 to 2025. Read , from the committed copy.
  • WHD Wage and Hour Division. Concluded cases to . Cases since fiscal year 2005. Read , from the agency.
  • USAspending USAspending.gov. Period the latest 12 months. Read , from the agency.

The site built this page on . The methodology tells how records are matched and counted. To report an error in the processing, use the corrections page. The agency that holds a record decides disputes about it.